These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 11349724

  • 1. Hyperuricemia exacerbates chronic cyclosporine nephropathy.
    Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA, Hughes J, Kivlighn SD, Lan HY, Johnson RJ.
    Transplantation; 2001 Apr 15; 71(7):900-5. PubMed ID: 11349724
    [Abstract] [Full Text] [Related]

  • 2. Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.
    Mazali FC, Johnson RJ, Mazzali M.
    Nephron Exp Nephrol; 2012 Apr 15; 120(1):e12-9. PubMed ID: 22126908
    [Abstract] [Full Text] [Related]

  • 3. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.
    Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, Andoh T, Bennett WM, Couser WG.
    Kidney Int; 1995 Aug 15; 48(2):439-48. PubMed ID: 7564111
    [Abstract] [Full Text] [Related]

  • 4. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy.
    Li C, Yang CW, Park JH, Lim SW, Sun BK, Jung JY, Kim SB, Kim YS, Kim J, Bang BK.
    Am J Physiol Renal Physiol; 2004 Jan 15; 286(1):F46-57. PubMed ID: 14519596
    [Abstract] [Full Text] [Related]

  • 5. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine.
    Li C, Yang CW, Kim WY, Jung JY, Cha JH, Kim YS, Kim J, Bennett WM, Bang BK.
    Am J Physiol Renal Physiol; 2003 Feb 15; 284(2):F389-98. PubMed ID: 12529276
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
    Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG.
    J Am Soc Nephrol; 1995 Oct 15; 6(4):1186-96. PubMed ID: 8589285
    [Abstract] [Full Text] [Related]

  • 7. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.
    Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ.
    Hypertension; 2001 Nov 15; 38(5):1101-6. PubMed ID: 11711505
    [Abstract] [Full Text] [Related]

  • 8. Pentosan polysulfate treatment reduces cyclosporine-induced nephropathy in salt-depleted rats.
    Schwedler SB, Bobadilla N, Striker LJ, Vaamonde CA, Herrera-Acosta J, Striker GE.
    Transplantation; 1999 Nov 27; 68(10):1583-8. PubMed ID: 10589959
    [Abstract] [Full Text] [Related]

  • 9. Uric acid--a uremic toxin?
    Nakagawa T, Mazzali M, Kang DH, Sánchez-Lozada LG, Herrera-Acosta J, Johnson RJ.
    Blood Purif; 2006 Nov 27; 24(1):67-70. PubMed ID: 16361844
    [Abstract] [Full Text] [Related]

  • 10. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
    Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, Johnson RJ.
    Kidney Int; 1998 Apr 27; 53(4):897-908. PubMed ID: 9551396
    [Abstract] [Full Text] [Related]

  • 11. Effect of FTY720 on chronic cyclosporine nephropathy in rats.
    Kim JY, Lim SW, Li C, Kim JS, Ahn KO, Yang HJ, Choi BS, Kim YS, Kim J, Bang BK, Yang CW.
    Transplantation; 2005 Nov 15; 80(9):1323-30. PubMed ID: 16314802
    [Abstract] [Full Text] [Related]

  • 12. Hyperuricemia influences chronic cyclosporine nephropathy.
    Saglam F, Celik A, Sarioglu S, Cavdar C, Sifil A, Gulay H, Camsari T.
    Transplant Proc; 2008 Nov 15; 40(1):167-70. PubMed ID: 18261576
    [Abstract] [Full Text] [Related]

  • 13. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M, Burke JF, McGowan TA, Zhu Y, Dunn SR, McCue P, Kanalas J, Sharma K.
    Kidney Int; 2001 Feb 15; 59(2):498-506. PubMed ID: 11168932
    [Abstract] [Full Text] [Related]

  • 14. Effects of cyclosporine in osteopontin null mice.
    Mazzali M, Hughes J, Dantas M, Liaw L, Steitz S, Alpers CE, Pichler RH, Lan HY, Giachelli CM, Shankland SJ, Couser WG, Johnson RJ.
    Kidney Int; 2002 Jul 15; 62(1):78-85. PubMed ID: 12081566
    [Abstract] [Full Text] [Related]

  • 15. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW, Ahn HJ, Kim WY, Li C, Jung JY, Yoon SA, Kim YS, Cha JH, Kim J, Bang BK.
    Transplantation; 2003 Feb 15; 75(3):309-15. PubMed ID: 12589150
    [Abstract] [Full Text] [Related]

  • 16. Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
    Asai T, Nakatani T, Yamanaka S, Tamada S, Kishimoto T, Tashiro K, Nakao T, Okamura M, Kim S, Iwao H, Miura K.
    Transplantation; 2002 Sep 27; 74(6):784-91. PubMed ID: 12364856
    [Abstract] [Full Text] [Related]

  • 17. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
    Shihab FS, Yi H, Bennett WM, Andoh TF.
    Kidney Int; 2000 Sep 27; 58(3):1174-85. PubMed ID: 10972680
    [Abstract] [Full Text] [Related]

  • 18. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL, Qin XC, Pan ZY, Chen K, Zhang YF, Cui WY, Liu GS, Wang H.
    J Hypertens; 2008 Dec 27; 26(12):2326-38. PubMed ID: 19008712
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation.
    Ling H, Li X, Jha S, Wang W, Karetskaya L, Pratt B, Ledbetter S.
    J Am Soc Nephrol; 2003 Feb 27; 14(2):377-88. PubMed ID: 12538738
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW, Ahn HJ, Kim WY, Li C, Kim HW, Choi BS, Cha JH, Kim YS, Kim J, Bang BK.
    Kidney Int; 2002 Jul 27; 62(1):20-30. PubMed ID: 12081560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.